Back to today’s briefing

Story perspectives

New Trial to Test Ambroxol's Impact on Parkinson's

4/1/2025

50 7

Summary

Story summary

The ASPro-PD trial is set to kick off in February 2025, aiming to explore the potential of ambroxol in slowing Parkinson's progression. Delays arose from necessary drug reformulation, but recruitment will span 15 UK sites, focusing on participants under 75 diagnosed within the last six years. Genetic screening will help identify GBA1 carriers crucial for the study.

1 of 1

Story summary

The ASPro-PD trial is set to kick off in February 2025, aiming to explore the potential of ambroxol in slowing Parkinson's progression. Delays arose from necessary drug reformulation, but recruitment will span 15 UK sites, focusing on participants under 75 diagnosed within the last six years. Genetic screening will help identify GBA1 carriers crucial for the study.